<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link href='https://unpkg.com/boxicons@2.1.4/css/boxicons.min.css' rel='stylesheet'>
    <title>Disease</title>
    <link rel="stylesheet" href="About_D.css">
</head>
<body>
    <div class="ALD">
        <div class="navigator">
            <h1 class="navheading">Neurodegenerative Diseases</h1>
        </div>
        <div id="disease_tab0" class="maincolumn ">
            <h1 class="diseasetitle">Adrenoleukodystrophy (ALD)</h1>
            <p class="aboutdisease"> ALD is a genetic disorder that primarily affects the white matter of the brain and the adrenal glands. It results from the accumulation of very long-chain fatty acids (VLCFAs) due to a defective peroxisomal enzyme. This leads to demyelination, the destruction of the protective myelin sheath surrounding nerve fibers.</p>
            <table class="tablecontents">
                <tr>
                    <th>Drug Names</th>
                    <th>Newest Drugs</th>
                    <th>Diagnosis</th>
                    <th>Treatment</th>
                    <th>Recent Advances</th>
                </tr>
                <tr>
                    <td> Lorenzo's oil (a mixture of erucic acid and oleic acid) can slow the progression of some forms of ALD.</td>
                    <td>Hematopoietic stem cell transplantation (HSCT) and gene therapy are showing promising results in clinical trials.</td>
                    <td>
                        <ul>
                            <li>Blood tests to measure VLCFA levels.</li>
                            <li>MRI of the brain to assess white matter abnormalities.</li>
                            <li>Genetic testing to identify mutations in the ABCD1 gene.</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li>HSCT can halt the progression of cerebral ALD if performed early.</li>
                            <li>Lorenzo's oil can slow the progression of some forms.</li>
                            <li>Gene therapy is an emerging treatment option.</li>
                            <li>Adrenal insufficiency treatment.</li>
                        </ul>
                    </td>
                    <td>Significant progress in gene therapy, offering potential for long-term disease modification.</td>
                </tr>
            </table>
        </div>
        <div id="disease_tab1" class="maincolumn active">
            <h2 class="diseasetitle">Alzheimer's Disease (AD)</h2>
            <p class="aboutdisease"> It is a progressive brain disorder that causes memory loss, cognitive decline, and behavioral changes. It is the most common cause of dementia, leading to difficulties in daily life. It results from abnormal protein buildup in the brain, damaging cells over time.</p>
            <table class="tablecontents">
                <tr>
                    <th>Drug Names</th>
                    <th>Newest Drugs</th>
                    <th>Diagnosis</th>
                    <th>Treatment</th>
                    <th>Recent Advances</th>
                </tr>
                <tr>
                    <td> 
                        <ul>
                            <li>Brexpiprazole</li>
                            <li>Donepezil</li>
                            <li>Galantamine</li>
                            <li>Benzgalantamine</li>
                            <li>Memantine</li>
                            <li>Lecanemab</li>
                            <li>Lecanemab</li>
                            <li>Donanemab</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li>Remternetug</li>
                            <li>Buntanetap</li>
                            <li>Semaglutide</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li>Medical history review</li>
                            <li>Cognitive tests</li>
                            <li>Blood tests</li>
                            <li>Brain imaging (CT, MRI, PET)</li>
                            <li>Cerebrospinal Fluid Analysis</li>
                            <li>Psychiatric Evaluati</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li>Medications: Donepezil, memantine</li>
                            <li>Therapies: Cognitive and behavioral support</li>
                            <li>Lifestyle: Diet, exercise, mental activities</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li>Disease-Modifying Therapies (DMTs): Targeting beta-amyloid accumulation.</li>
                            <li>Protein Regulation: Compounds like 4-phenylbutyrate (PBA) reducing protein buildup.</li>
                            <li>Glutamate Modulation: Drugs like Troriluzole lowering harmful glutamate levels.</li>
                            <li>Microglia Research: Exploring brain immune cells for new treatment targets.</li>
                        </ul>
                    </td>
                </tr>
            </table>
        </div>
        <div id="disease_tab2" class="maincolumn">
            <h1 class="diseasetitle">Alexander Disease</h1>
            <p class="aboutdisease"> A rare progressive leukodystrophy characterized by the abnormal accumulation of glial fibrillary acidic protein (GFAP) in astrocytes, the brain's support cells.</p>
            <table class="tablecontents">
                <tr>
                    <th>Drug Names</th>
                    <th>Newest Drugs</th>
                    <th>Diagnosis</th>
                    <th>Treatment</th>
                    <th>Recent Advances</th>
                </tr>
                <tr>
                    <td>There are no specific medications to cure or reverse Alexander disease. Treatment focuses on managing symptoms.</td>
                    <td>Research into GFAP targeted therapies is ongoing.</td>
                    <td>
                        <ul>
                            <li>MRI of the brain to identify characteristic white matter abnormalities.</li>
                            <li> Genetic testing to confirm mutations in the GFAP gene.</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li>Symptomatic management, including physical therapy, occupational therapy, and medications to control seizures.</li>
                            <li>Supportive care.</li>
                        </ul>
                    </td>
                    <td>
                        <ul>
                            <li> Increased understanding of the role of GFAP in the disease process.</li>
                            <li>Research into potential gene therapies.</li>
                        </ul>
                    </td>
                </tr>
            </table>
        </div>
    </div>
    <script src="neuro.js"></script>
</body>
</html>